These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35858498)

  • 1. Fulminant neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccination: A need for reconsideration?
    Motahharynia A; Naghavi S; Shaygannejad V; Adibi I
    Mult Scler Relat Disord; 2022 Oct; 66():104035. PubMed ID: 35858498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newly diagnosed neuromyelitis optica spectrum disorders following vaccination: Case report and systematic review.
    Anamnart C; Tisavipat N; Owattanapanich W; Apiwattanakul M; Savangned P; Prayoonwiwat N; Siritho S; Rattanathamsakul N; Jitprapaikulsan J
    Mult Scler Relat Disord; 2022 Feb; 58():103414. PubMed ID: 35216789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aquaporin-4 IgG neuromyelitis optica spectrum disorder onset after Covid-19 vaccination: Systematic review.
    Harahsheh E; Callister M; Hasan S; Gritsch D; Valencia-Sanchez C
    J Neuroimmunol; 2022 Dec; 373():577994. PubMed ID: 36332464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe disease exacerbation after mRNA COVID-19 vaccination unmasks suspected multiple sclerosis as neuromyelitis optica spectrum disorder: a case report.
    Lohmann L; Glaser F; Möddel G; Lünemann JD; Wiendl H; Klotz L
    BMC Neurol; 2022 May; 22(1):185. PubMed ID: 35585528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19.
    Chen S; Fan XR; He S; Zhang JW; Li SJ
    Neurol Sci; 2021 Sep; 42(9):3537-3539. PubMed ID: 34189662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First manifestation of AQP4-IgG-positive neuromyelitis optica spectrum disorder following the COVID-19 mRNA vaccine BNT162b2.
    Umezawa S; Ioka K; Aizawa S; Tashiro Y; Yoshizawa K
    Neurol Sci; 2023 Feb; 44(2):451-455. PubMed ID: 36289118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Watch out for neuromyelitis optica spectrum disorder onset or clinical relapse after COVID-19 vaccination: What neurologists need to know?
    Paybast S; Emami A; Baghalha F; Naser Moghadasi A
    Mult Scler Relat Disord; 2022 Sep; 65():103960. PubMed ID: 35763914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the safety profile of COVID-19 vaccines in patients with MS, NMOSD, and MOGAD.
    Kim S; Seok HY
    Neurol Sci; 2023 Jun; 44(6):1841-1848. PubMed ID: 36781562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between infections, the microbiome, vaccination, and neuromyelitis optica spectrum disorder.
    Carnero Contentti E; Correale J
    Mult Scler; 2023 Apr; 29(4-5):492-501. PubMed ID: 35903896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optic Neuritis Following the BNT162b2 mRNA COVID-19 Vaccine in a Patient with Systemic Lupus Erythematosus Uncovering the Diagnosis of Neuromyelitis Optica Spectrum Disorders.
    Shirah B; Mulla I; Aladdin Y
    Ocul Immunol Inflamm; 2023 Aug; 31(6):1213-1215. PubMed ID: 35849732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 infection after two doses of SARS-CoV-2 mRNA vaccine in multiple sclerosis, AQP4-antibody NMOSD and MOGAD.
    Yeo T; Quek AML; Yong KP; Tye JSN; Ratnagopal P; Soon DTL; Tan K
    Mult Scler Relat Disord; 2022 Sep; 65():104003. PubMed ID: 35803084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy challenges for NMOSD in a patient with HIV.
    Engels D; Havla J; Förderreuther S; Kümpfel T
    Mult Scler; 2023 Dec; 29(14):1872-1875. PubMed ID: 37712413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relapses after SARS-CoV-2 vaccination in patients with neuromyelitis optica spectrum disorder and multiple sclerosis.
    Kong L; Wang X; Chen H; Shi Z; Lang Y; Zhang Y; Zhou H
    Mult Scler Relat Disord; 2022 Dec; 68():104167. PubMed ID: 36170773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AQP4-IgG-seropositive neuromyelitis optica spectrum disorder (NMOSD) coexisting with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: A case report and literature review.
    Tao S; Zhang Y; Ye H; Guo D
    Mult Scler Relat Disord; 2019 Oct; 35():185-192. PubMed ID: 31398657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD.
    Dinoto A; Sechi E; Ferrari S; Gajofatto A; Orlandi R; Solla P; Maccabeo A; Maniscalco GT; Andreone V; Sartori A; Manganotti P; Rasia S; Capra R; Mancinelli CR; Mariotto S
    Mult Scler Relat Disord; 2022 Feb; 58():103424. PubMed ID: 35216793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination in neuromyelitis optica spectrum disorders: Friend or enemy?
    Cai H; Zhou R; Jiang F; Zeng Q; Yang H
    Mult Scler Relat Disord; 2022 Feb; 58():103394. PubMed ID: 35216775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 vaccine response in Neuromyelitis Optica Spectrum Disorder.
    Baba C; Kaya E; Ozcelik S; Ozdogar AT; Samadzade U; Cevik S; Calıskan C; Dogan Y; Ozakbas S
    Clin Neurol Neurosurg; 2024 Mar; 238():108152. PubMed ID: 38382130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and emerging therapeutics for neuromyelitis optica spectrum disorder: Relevance to the COVID-19 pandemic.
    Abboud H; Zheng C; Kar I; Chen CK; Sau C; Serra A
    Mult Scler Relat Disord; 2020 Sep; 44():102249. PubMed ID: 32526698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-COVID Neuromyelitis Optica Spectrum Disorder.
    Rafique S; Wasim A; Sultan T; Ahmad A
    J Coll Physicians Surg Pak; 2021 Jul; 31(7):138-140. PubMed ID: 34271816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late onset neuromyelitis optica spectrum disorder with anti-aquaporin 4 and anti-myelin oligodendrocyte glycoprotein antibodies.
    Wang L; Tan H; Huang W; Chang X; ZhangBao J; Zhou L; Lu C; Wang M; Lu J; Zhao C; Quan C
    Eur J Neurol; 2022 Apr; 29(4):1128-1135. PubMed ID: 34967093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.